Bristol-Myers Squibb Named First on 2014 Best Corporate Citizens List
PTSM: Pharmaceutical Technology Sourcing and Management
Bristol-Myers Squibb is named No. 1 on 2014 Best Corporate Citizens List for the third time in six years.
Bristol-Myers Squibb has been ranked No. 1 on Corporate Responsibility magazine’s 2014 list of the 100 Best Corporate Citizens, a benchmark for socially responsible investors and other stakeholders. Bristol-Myers Squibb has achieved the No. 1 ranking three times, including 2009 and 2012, and has ranked among the top 10 for the past six years.
The 100 Best Corporate Citizens list ranks companies in the Russell 1000 using nearly 300 data points in seven categories: environment, climate change, employee relations, human rights, governance, finance, and philanthropy.
Source: Bristol-Myers Squibb
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Cosette Pharmaceuticals Adds to Dermatology and Women’s Health Portfolio with Mayne Pharma Purchase
Published: February 26th 2025 | Updated: February 26th 2025While the boards of directors of both companies have approved the transaction, it is not expected to close until the second quarter of 2025, as Mayne Pharma’s shareholders must still vote in favor of the acquisition.
FDA Approves First Treatment for Rare Lipid Storage Disease Cerebrotendinous Xanthomatosis
February 24th 2025Cerebrotendinous xanthomatosis, or CTX, is a metabolic disorder caused by a gene mutation that results in a deficiency of an important enzyme in the ability of the human body to break down fats.
